Planning notice · Contracts Finder
Diabetes - Hybrid Closed Loop (HCL) Technology
Part of Diabetes - Hybrid Closed Loop (HCL) Technology.
NICE is undertaking a Technology Appraisal (TA) for hybrid closed loop systems (HCL) for managing blood glucose levels in type 1 diabetes. As part of this TA, NHS England have been requested by NICE to assist NICE with gathering information on the pricing of HCL technologies. The outputs of this information gathering exercise will inform the NICE Appraisal Committee as to whether HCL can be recommended as a cost-effective treatment option for eligible patients. NHS Supply Chain, as the primary NHS co-ordinator of the supply of this technology, have been requested to undertake this Request…
- Buyer
- NHS Supply Chain
- Published
- 11 Aug 2023
- Status
- planning
- CPV
- 33615000 — Medicinal products used in diabetes
- Tender period
- —
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a planning notice published via Contracts Finder on 11 Aug 2023.
Which procurement does this notice belong to?
It is part of "Diabetes - Hybrid Closed Loop (HCL) Technology", published by NHS Supply Chain.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable